Voriconazole Injection IP

Trade Name: VoriCure
Available Strength : 200 mg
Available Combination : Voriconazole Injection IP is a triazole antifungal containing voriconazole as the active ingredient, used for the treatment of serious invasive fungal infections.
Packing : vial
Pack Insert/Leaflet : YES
Therapeutic use : Voriconazole Injection IP is a triazole antifungal agent used to treat serious and life-threatening fungal infections, including invasive aspergillosis, candidemia, and other severe Candida or fungal infections. It works by inhibiting fungal cell membrane synthesis and is commonly used in immunocompromised patients or when infections are resistant to other antifungal therapies.
Capacity : 100000

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.